322 related articles for article (PubMed ID: 31344286)
1. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
Karaman E; Ilkit M; Kuşçu F
Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a rapid lateral flow immunoassay for the detection of cryptococcal antigen for the early diagnosis of cryptococcosis in HIV patients in Colombia.
Escandón P; Lizarazo J; Agudelo CI; Chiller T; Castañeda E
Med Mycol; 2013 Oct; 51(7):765-8. PubMed ID: 23611420
[TBL] [Abstract][Full Text] [Related]
3. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
[TBL] [Abstract][Full Text] [Related]
4. Multicenter Cryptococcal Antigen Screening of HIV-Infected Patients in Iran.
Bandalizadeh Z; Shokohi T; Moosazadeh M; Keikha N; Seyedpor H; Rabie Rudsari M; Babamahmoudi F; Ghasemian R; Mardani M; Javanian M; Soleimanpour S; Sefidgar AA; Shokri M; Gouya MM; Seyedmousavi S
Curr Microbiol; 2020 Aug; 77(8):1667-1672. PubMed ID: 32296917
[TBL] [Abstract][Full Text] [Related]
5. Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/μl identifies districts in South Africa with advanced burden of disease.
Coetzee LM; Cassim N; Sriruttan C; Mhlanga M; Govender NP; Glencross DK
PLoS One; 2018; 13(6):e0198993. PubMed ID: 29894509
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis.
Kwizera R; Omali D; Tadeo K; Kasibante J; Rutakingirwa MK; Kagimu E; Ssebambulidde K; Williams DA; Rhein J; Boulware D; Meya DB
J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33268538
[TBL] [Abstract][Full Text] [Related]
7. Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.
Sawadogo S; Makumbi B; Purfield A; Ndjavera C; Mutandi G; Maher A; Kaindjee-Tjituka F; Kaplan JE; Park BJ; Lowrance DW
PLoS One; 2016; 11(10):e0161830. PubMed ID: 27760140
[TBL] [Abstract][Full Text] [Related]
8. Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/μl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa.
Cassim N; Schnippel K; Coetzee LM; Glencross DK
PLoS One; 2017; 12(2):e0171675. PubMed ID: 28166254
[TBL] [Abstract][Full Text] [Related]
9. Serum Cryptococcal Antigen Testing in Immunosuppressed HIV-positive Children and Adolescents.
Zuma P; Ramsamy Y; Mlisana K; Archary M
Pediatr Infect Dis J; 2020 Mar; 39(3):217-220. PubMed ID: 31725553
[TBL] [Abstract][Full Text] [Related]
10. Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania.
Magambo KA; Kalluvya SE; Kapoor SW; Seni J; Chofle AA; Fitzgerald DW; Downs JA
J Int AIDS Soc; 2014; 17(1):19040. PubMed ID: 25109284
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and outcomes of cryptococcal antigenemia in HIV-seropositive patients hospitalized for suspected tuberculosis in Uganda.
Andama AO; den Boon S; Meya D; Cattamanchi A; Worodria W; Davis JL; Walter ND; Yoo SD; Kalema N; Haller B; Huang L;
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):189-94. PubMed ID: 23542636
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon Basin.
Assy JGPL; Said RDC; Pinheiro OC; Brandão ADS; Boulware DR; França FOS; Vidal JE
Med Mycol; 2021 Sep; 59(9):909-915. PubMed ID: 33908611
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu-Natal.
Drain PK; Kleene JM; Coleman SM; Losina E; Katz JN; Giddy J; Ross D; Freedberg KA; Bassett IV
HIV Med; 2015 Nov; 16(10):640-4. PubMed ID: 25958770
[TBL] [Abstract][Full Text] [Related]
14. Point-of-Care Testing for Cryptococcal Disease Among Hospitalized Human Immunodeficiency Virus-Infected Adults in Ethiopia.
Mamuye AT; Bornstein E; Temesgen O; Blumberg HM; Kempker RR
Am J Trop Med Hyg; 2016 Oct; 95(4):786-792. PubMed ID: 27527636
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency department.
Oliveira FG; Nakagawa JAS; de Oliveira JMM; Júnior RML; Marcusso R; Vidal JE
Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37656871
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.
McKenney J; Bauman S; Neary B; Detels R; French A; Margolick J; Doherty B; Klausner JD
Clin Infect Dis; 2015 Mar; 60(6):959-65. PubMed ID: 25422390
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.
Meya DB; Manabe YC; Castelnuovo B; Cook BA; Elbireer AM; Kambugu A; Kamya MR; Bohjanen PR; Boulware DR
Clin Infect Dis; 2010 Aug; 51(4):448-55. PubMed ID: 20597693
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcosis in HIV-infected hospitalized patients in Germany: Evidence for routine antigen testing.
Katchanov J; Jefferys L; Tominski D; Wöstmann K; Slevogt H; Arastéh K; Stocker H
J Infect; 2015 Jul; 71(1):110-6. PubMed ID: 25644318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
